title: Bone-anchored hearing device placement with translabyrinthine tumor removal.
abstract: OBJECTIVE
  Translabyrinthine resection of intracranial tumors results in single-sided deafness, which can be treated by surgical and nonsurgical means. Here we describe the first series examining complication and device usage rates among patients receiving a surgically implanted bone-anchored hearing device (BAHD) at the time of translabyrinthine tumor removal.
  
  
  METHODS
  Case series with chart review.
  
  
  METHODS
  Private tertiary neurotologic referral center.
  
  
  METHODS
  Patients (N = 154) undergoing concurrent BAHD placement and translabyrinthine tumor resection.
  
  
  METHODS
  Concurrent BAHD placement and translabyrinthine tumor removal.
  
  
  METHODS
  Postoperative complication rates and BAHD usage.
  
  
  RESULTS
  Of the 154 patients, 121 (78.6%) had no device-related complications. The most common device-related complications were skin overgrowth (8.4%), acute infection (5.2%), and chronic infection (3.2%). The overall and specific complication rates did not differ from published BAHD complication rates. One patient (0.6%) developed a cerebrospinal leak through the surgical site for the device. At the time of last follow-up (mean, 39.8 months), 151 patients (95.0%) were still using their devices.
  
  
  CONCLUSIONS
  Patients undergoing concurrent translabyrinthine tumor removal and BAHD placement exhibit similar device-related complication profiles as patients undergoing standard device placement. Based on these outcomes and the high long-term usage rates, BAHD insertion at the time of translabyrinthine intracranial surgery can be considered a safe and useful procedure.
authors.affiliation: House Clinic, Los Angeles, California, USA.
authors.forename: Theodore R
authors.initials: TR
authors.lastname: McRackan
authors.affiliation: House Clinic, Los Angeles, California, USA.
authors.forename: John C
authors.initials: JC
authors.lastname: Goddard
authors.affiliation: House Clinic, Los Angeles, California, USA.
authors.forename: Eric P
authors.initials: EP
authors.lastname: Wilkinson
authors.affiliation: House Clinic, Los Angeles, California, USA.
authors.forename: William H
authors.initials: WH
authors.lastname: Slattery
authors.affiliation: House Clinic, Los Angeles, California, USA dbrackmann@hei.org.
authors.forename: Derald E
authors.initials: DE
authors.lastname: Brackmann
mesh_terms: D007758:Ear, Inner / Q000601:surgery*; D005260:Female; D006310:Hearing Aids; D046088:Hearing Loss, Unilateral / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009464:Neuroma, Acoustic / Q000601:surgery*; D011183:Postoperative Complications / Q000601:surgery*; D019919:Prosthesis Implantation / Q000379:methods*; D053441:Suture Anchors; D016896:Treatment Outcome
keywords: acoustic neuroma; bone-anchored hearing aid; bone-anchored hearing device; single-sided deafness; translabyrinthine; vestibular schwannoma